Cardiometabolic risk factors and health behaviors in family caregivers.
Alyson RossRobert ShamburekLeslie WehrlenStephen D KlagholzLi YangElyssa StoopsSharon L FlynnAlan T RemaleyKarel PacakNonniekaye ShelburneMargaret F BevansPublished in: PloS one (2017)
The purpose of this study was to compare components of cardiometabolic risk and health behaviors of 20 family caregivers of allogeneic hematopoietic stem cell transplant patients to those of age, gender, and race/ethnicity-matched controls. A prospective, repeated measures design was used to compare cardiometabolic risk and health behaviors in caregivers and controls at three time-points: pre-transplantation, discharge, and six weeks post-discharge. Measures included components of metabolic syndrome, Reynolds Risk Score, NMR serum lipoprotein particle analyses, and the Health-Promoting Lifestyle Profile II (HPLP-II). Mixed-model repeated measure analyses were used. There were no between or within group differences in LDL cholesterol, HDL cholesterol, and triglycerides. There was a significant interaction effect between time and role in large VLDL concentration (VLDL-P) (F (2, 76) = 4.36, p = .016), with the trajectory of large VLDL-P increasing over time in caregivers while remaining stable in controls. Within caregivers, VLDL particle size (VLDL-Z) was significantly larger at time-point three compared to time-points one (p = .015) and two (p = .048), and VLDL-Z was significantly larger in caregivers than in controls at time point three (p = .012). HPLP-II scores were lower in caregivers than controls at all time-points (p < .01). These findings suggest that caregiving may have a bigger impact on triglycerides than on other lipids, and it is through this pathway that caregivers may be at increased cardiometabolic risk. More sensitive measurement methods, such as NMR lipoprotein particle analyses, may be able to detect early changes in cardiometabolic risk.
Keyphrases
- palliative care
- healthcare
- metabolic syndrome
- public health
- mental health
- low density lipoprotein
- risk factors
- hematopoietic stem cell
- magnetic resonance
- health information
- high resolution
- end stage renal disease
- bone marrow
- cardiovascular disease
- ejection fraction
- newly diagnosed
- physical activity
- stem cell transplantation
- chronic kidney disease
- risk assessment
- social media
- low dose
- high density
- solid state
- mesenchymal stem cells
- mass spectrometry
- patient reported outcomes
- adipose tissue